{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiatsdeovlzozto3xsgmz4uayf6m6zrwkudflvu6mw7fgadkhyw3de",
    "uri": "at://did:plc:5v5xdyhb3zf74bcdmcnazkrk/app.bsky.feed.post/3mgdkpmuesp52"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiddyzigig6rtqggqzykb7vwk2wwrj6yywco5dpw5kvcdgo3lufmdi"
    },
    "mimeType": "image/jpeg",
    "size": 56144
  },
  "path": "/medicine/diseases-medicine/a-new-type-of-immunotherapy-drug-for-prostate-cancer-shows-up-to-99-drop-in-cancer-biomarkers/",
  "publishedAt": "2026-03-05T17:59:51.000Z",
  "site": "https://www.zmescience.com",
  "tags": [
    "Diseases",
    "Health",
    "News",
    "cancer research",
    "clinical trial",
    "immunotherapy",
    "oncology",
    "prostate cancer",
    "T-cell engager",
    "targeted therapy",
    "tumor microenvironment",
    "VIR-5500"
  ],
  "textContent": "A new Trojan horse drug is helping the immune system find and kill prostate cancer cells for the first time.",
  "title": "A New Type of Immunotherapy Drug for Prostate Cancer Shows Up to 99% Drop in Cancer Biomarkers"
}